Trials of new antithrombin agents
With increasing pressure on the medical community to conserve resources wherever possible, practising clinicians must become more involved in clinical investigations designed to determine which therapies are effective and which are not. With this goal in mind, JMI is introducing a new department, 'Clinical Trials in Progress,' which will feature capsule summaries of ongoing and recently completed trials in ischemic heart disease. The first in this series of articles focuses on trials of new antithrombin agents, an area of intense current clinical activity.
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)